Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00034925.xml
Hamostaseologie 2011; 31(03): 150
DOI: 10.1055/s-0037-1619737
DOI: 10.1055/s-0037-1619737
In eigener Sache
Impact-Faktor für die Hämostaseologie
Dank an Autoren und GutachterFurther Information
Publication History
Publication Date:
28 December 2017 (online)
-
Literatur
- 1 Boon RA, Horrevoers AJG. Key transcriptional regulators of the vasoprotective effects of shear stress. Hämostaseologie 2009; 29: 39-43.
- 2 Alban S. Pharmakologie der Heparin und direkten Antikoagulanzien. Hämostaseologie 2008; 28: 400-420.
- 3 Perzborn E. Factor Xa inhibitors: New anticoagulants for secondary haemostasis. Hämostaseologie 2009; 29: 260-267.
- 4 Scharf RE. Erworbene Plättchenfunktionsstörungen: Pathogenese, Klassifikation, Häufigkeit, Diagnostik und Behandlung. Hämostaseologie 2008; 28: 299-311.
- 5 Turecek PL, Mitterer A, Matthiessen HP. et al. Development of a plasma-and albumin-free recombinant von Willebrand factor. Hämostaseologie 2009; 29 (Suppl. 01) S32-S38.
- 6 Zieger B, Jenny A, Tsakiris DA. et al. A large Swiss family with Bernard-Soulier syndrome. Correlation phenotype and genotype. Hämostaseologie 2009; 29: 161-167.
- 7 Mann KG, Orfeo T, Butenas S. et al. Blood coagulation dynamics in haemostasis. Hämostaseologie 2009; 29: 7-16.
- 8 Harrison P. Assessment of platelet function in the laboratory. Hämostaseologie 2009; 29: 25-31.